114 related articles for article (PubMed ID: 27468886)
1. Clinical value of high expression level of CD71 in acute myeloid leukemia.
Wu B; Shi N; Sun L; Liu L
Neoplasma; 2016; 63(5):809-15. PubMed ID: 27468886
[TBL] [Abstract][Full Text] [Related]
2. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
Liu Q; Wang M; Hu Y; Xing H; Chen X; Zhang Y; Zhu P
Leuk Lymphoma; 2014 Apr; 55(4):892-8. PubMed ID: 23962073
[TBL] [Abstract][Full Text] [Related]
3. Role of CD71 in acute leukemia- An immunophenotypic marker for erythroid lineage or proliferation?
Acharya S; Kala PS
Indian J Pathol Microbiol; 2019; 62(3):418-422. PubMed ID: 31361230
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia.
Pande A; Dorwal P; Jain D; Tyagi N; Mehra S; Sachdev R; Raina V
Indian J Pathol Microbiol; 2016; 59(3):310-3. PubMed ID: 27510666
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Transferrin Receptor-1 (CD71) Expression in Acute Lymphoblastic Leukemia.
Hagag AA; Badraia IM; Abdelmageed MM; Hablas NM; Hazzaa SME; Nosair NA
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):610-617. PubMed ID: 29875008
[TBL] [Abstract][Full Text] [Related]
6. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
Schaar DG; Medina DJ; Moore DF; Strair RK; Ting Y
Exp Hematol; 2009 Feb; 37(2):245-55. PubMed ID: 19135902
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.
Del Poeta G; Del Principe MI; Maurillo L; Rossi FM; Buccisano F; Ammatuna E; Simotti C; Zucchetto A; Catalano G; Bulian P; Bruno A; Venditti A; De Fabritiis P; Gattei V; Amadori S
Leuk Lymphoma; 2010 Jan; 51(1):95-106. PubMed ID: 20001236
[TBL] [Abstract][Full Text] [Related]
8. Affinity separation and subsequent terminal differentiation of acute myeloid leukemia cells using the human transferrin receptor (CD71) as a capture target.
Lyons VJ; Pappas D
Analyst; 2019 May; 144(10):3369-3380. PubMed ID: 30984961
[TBL] [Abstract][Full Text] [Related]
9. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
10. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
Marsee DK; Pinkus GS; Yu H
Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
[TBL] [Abstract][Full Text] [Related]
11. Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia.
Płoszyńska A; Ruckemann-Dziurdzińska K; Jóźwik A; Mikosik A; Lisowska K; Balcerska A; Witkowski JM
Folia Histochem Cytobiol; 2012 Jul; 50(2):304-11. PubMed ID: 22763969
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.
Suzuki S; Ogino N; Mitsui I; Ito H; Kariya T
J Vet Diagn Invest; 2021 Jan; 33(1):87-94. PubMed ID: 33225861
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia.
Kollia P; Stavroyianni N; Stamatopoulos K; Zoi K; Viniou N; Mantzourani M; Noguchi CT; Paterakis G; Abazis D; Pangalos C; Loukopoulos D; Yataganas X
Br J Haematol; 2001 Oct; 115(1):19-24. PubMed ID: 11722405
[TBL] [Abstract][Full Text] [Related]
14. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia.
Smilevska T; Stamatopoulos K; Samara M; Belessi C; Tsompanakou A; Paterakis G; Stavroyianni N; Athanasiadou I; Chiotoglou I; Hadzidimitriou A; Athanasiadou A; Douka V; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A; Stathakis N; Kollia P
Leuk Res; 2006 Feb; 30(2):183-9. PubMed ID: 16054692
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
[TBL] [Abstract][Full Text] [Related]
17. Two methods for the quantitative analysis of surface antigen expression in acute myeloid leukemia (AML).
Woźniak J
Folia Histochem Cytobiol; 2004; 42(3):195-9. PubMed ID: 15493582
[TBL] [Abstract][Full Text] [Related]
18. α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.
Yu H; Pinkus JL; Pinkus GS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):51-6. PubMed ID: 25611244
[TBL] [Abstract][Full Text] [Related]
19. Transferrin receptor expression as a marker of immature cycling thymocytes in the mouse.
Brekelmans P; van Soest P; Voerman J; Platenburg PP; Leenen PJ; van Ewijk W
Cell Immunol; 1994 Dec; 159(2):331-9. PubMed ID: 7994765
[TBL] [Abstract][Full Text] [Related]
20. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].
Li L; Lyu XD; Mi RH; Ding J; Chen L; Wang Q; Yin QS; Hu JY; Fan RH; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):601-6. PubMed ID: 23815906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
